SecBot SecBot
Insider Cluster (5 insiders) ·Filed Jun 11, 2026

AXSM

Axsome Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed5mo ago
Insider cluster: 5 insiders, $20.2M total
Actionable Insight • Neutral

The insider selling, while notable in absolute dollars, is moderate relative to market cap and appears tied to option exercises. No bearish read-through is warranted. Monitor for any upcoming corporate announcements or earnings that could provide context for why key executives executed sales at this juncture.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$255.17
T+0 close · Jun 11, 2026 · via day close
Latest settled
−18.56%
T+60 · $207.82
Vs SPY
−21.82%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 12 $255.17entry
  2. T+1 · 5mo ago −0.69%α −2.46% · $253.40
  3. T+5 · 5mo ago −1.83%α −2.50% · $250.50
  4. T+20 · 4mo ago −8.37%α −10.15% · $233.80
  5. T+60 · 2mo ago −18.56%α −21.82% · $207.82
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A cluster of insider sales at Axsome Therapeutics (AXSM) over the past week totaled ~$20.2M in open-market transactions, led by CEO Herriot Tabuteau ($12.0M) and CFO Nick Pizzie ($7.9M). Director-level sales were minor. At 0.16% of market cap, the selling is modest and likely reflects planned exercises and diversification rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$20.2M
Insiders
5

Key Facts

  • CEO sold 49,670 shares at $241.01 for $11.97M on June 9.
  • CFO sold 33,000 shares at $240.09 for $7.92M on June 9.
  • Three directors sold aggregate ~$304K in small lots.
  • Total open-market selling cluster value: ~$20.2M (0.16% of $12.7B market cap).
  • All CEO and CFO sales followed derivative exercises (non-cash), consistent with planned transactions.
  • No material corporate news or catalyst identified in the filing window.

Financial Impact

~$20.2M in insider open-market sales over 2 days, representing 0.16% of market cap, modest and routine.

insider holdingsfloat

Risk Factors

  • If future filings reveal a lack of pre-arranged trading plans, the selling could indicate reduced confidence.
  • Continued insider selling at current levels might pressure sentiment among retail holders.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (27 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-AXSM-1781224472996

Track record

26 reports on AXSM

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +14.74% at T+60 after the Apr 30, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 2, 202614d ago 8-K Bullish 6/10 No price data
  2. Nov 2, 202614d ago Press Release Bullish 6/10 Entry $136.01 to $133.96 Now $137.01 +0.74% ▼ −1.51% −1.59% vs SPY
  3. Oct 20, 202627d ago Institutional Cluster Bearish 4/10 Entry $156.31 to $142.20 Now $137.01 +12.35% ▲ +9.03% +8.58% vs SPY
  4. Aug 11, 202613w ago Institutional Cluster Mixed 5/10 Entry $214.66 to $218.20 Now $137.01 −36.17% ▲ +1.65% +2.09% vs SPY
  5. Aug 10, 202614w ago 8-K Neutral 6/10 No price data
  6. Aug 10, 202614w ago Press Release Mixed 6/10 Entry $220.89 to $216.27 Now $137.01 −37.97% ▼ −2.09% −2.04% vs SPY
  7. Jul 15, 202617w ago Press Release Bullish 6/10 Entry $237.53 to $239.62 Now $137.01 −42.32% ▲ +0.88% +1.86% vs SPY
  8. Jul 9, 202618w ago Court Ruling Bullish 5/10 Entry $248.95 to $237.04 Now $137.01 −44.96% ▼ −4.78% −4.65% vs SPY
  9. Jul 7, 202618w ago Press Release Neutral 4/10 Entry $249.76 to $235.26 Now $137.01 −45.14% ▼ −5.81% −6.36% vs SPY
  10. Jul 1, 202619w ago 144 Neutral 4/10 Entry $244.31 to $248.95 Now $137.01 −43.92% ▲ +1.90% +0.97% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens in 7h 49m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026